Allen Meglin - Aug 19, 2022 Form 4 Insider Report for Organicell Regenerative Medicine, Inc. (OCEL)

Role
Director
Signature
/s/ Allen Meglin
Stock symbol
OCEL
Transactions as of
Aug 19, 2022
Transactions value $
$0
Form type
4
Date filed
8/24/2022, 04:54 PM
SEC
View on sec.gov

Transactions Table

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Allen Meglin is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The Reporting Person is filing this Form 4 to report his resignation as a director of the Issuer effective August 19, 2022 and his beneficially owned holdings in the Issuer as of such date.